相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improved Speciation Characteristics of PEGylated Indocyanine Green-Labeled Panitumumab: Revisiting the Solution and Spectroscopic Properties of a Near-Infrared Emitting anti-HER1 Antibody for Optical Imaging of Cancer
Aaron Joseph L. Villaraza et al.
BIOCONJUGATE CHEMISTRY (2010)
Positive Progress in ImmunoPET-Not Just a Coincidence
Katelyn E. McCabe et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-AaEuro3-DTPA-cetuximab
Tapan K. Nayak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with 86Y for Quantitative PET of Carcinoma
Tapan K. Nayak et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Epidermal Growth Factor Receptor-Targeted Radioimmunotherapy of Human Head and Neck Cancer Xenografts Using 90Y-Labeled Fully Human Antibody Panitumumab
Zhaofei Liu et al.
MOLECULAR CANCER THERAPEUTICS (2010)
MONICA: a compact, portable dual gamma camera system for mouse whole-body imaging
Wenze Xi et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Antibody Vectors for Imaging
Tove Olafsen et al.
SEMINARS IN NUCLEAR MEDICINE (2010)
Preclinical evaluation of a monoclonal antibody targeting the epidermal growth factor receptor as a radioimmunodiagnostic and radioimmunotherapeutic agent
G. L. Ray et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
Gang Niu et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Cetuximab: Preclinical Evaluation of a Monoclonal Antibody Targeting EGFR for Radioimmunodiagnostic and Radioimmunotherapeutic Applications
Diane E. Milenic et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence Imaging agent for monoclonal antibody tumor-targeted imaging
Heng Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Biodistribution and planar gamma camera imaging of 123I- and 131I-labeled F(ab′)2 and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor
Ingrid J. G. Burvenich et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
FDA drug approval summary: Panitumumab (Vectibix (TM))
Ruthann M. Giusti et al.
ONCOLOGIST (2007)
Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers
GP Adams et al.
CLINICAL CANCER RESEARCH (2006)
Elimination mechanisms of therapeutic monoclonal antibodies
MA Tabrizi et al.
DRUG DISCOVERY TODAY (2006)
In vivo evaluation of 177Lu- and 67/64Cu-labelled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors
J Grünberg et al.
CLINICAL CANCER RESEARCH (2005)
Human/murine chimeric 8 1C6 F(ab′)2 fragment:: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma
A Boskovitz et al.
NUCLEAR MEDICINE AND BIOLOGY (2004)
Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody
D Milenic et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors
PM Smith-Jones et al.
NATURE BIOTECHNOLOGY (2004)
A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™
K Garmestani et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications
DE Milenic et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
Stable, genetically engineered F(ab′)2 fragments of chimeric TNT-3 expressed in mammalian cells
LA Khawli et al.
HYBRIDOMA AND HYBRIDOMICS (2002)
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies
RJ Ober et al.
INTERNATIONAL IMMUNOLOGY (2001)
In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates
DE Milenic et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Radioimmunotherapy: Designer molecules to potentiate effective therapy
DE Milenic
SEMINARS IN RADIATION ONCOLOGY (2000)
分享论文
